介酶干细胞衍生微RNA: 预防眼部组织退化的主要免疫调节剂
Sneha Nair1,2, Gowri Priya Chidambaranathan1,3
1Department of Immunology and Stem Cell Biology, Aravind Medical Research Foundation, Madurai 625020, Tamil Nādu, India.
World journal of stem cells
|November 3, 2025
概括
介质细胞干细胞衍生的微RNA (miRNA) 显示出治疗眼睛疾病的前景,如干眼和青光眼. 这些微小的RNA分子,通常通过细胞外囊泡传递,为眼部疾病提供了一条新的治疗途径.
科学领域:
- 生物医学科学 生物医学科学
- 再生医学是一种再生医学.
- 眼科医生 眼科 眼科
背景情况:
- 微RNA (miRNA) 是小型非编码RNA,可以调节基因表达.
- 介酶干细胞 (MSC) 和它们的密体,富含miRNAs,调节关键的生物过程.
- 眼部疾病涉及复杂的途径,包括炎症和亡.
研究的目的:
- 审查MSC衍生的miRNAs在眼科中的治疗应用.
- 探索携带miRNA的细胞外囊泡在眼睛健康中的作用.
- 讨论生物工程纳米纤维用于眼睛中的向miRNA输送.
主要方法:
- 关于MSC衍生的miRNA和眼部疾病的研究文献综述.
- 对细胞外囊泡作为miRNA输送载体的研究分析.
- 对基于纳米纤维的miRNA治疗方法的生物工程策略的检查.
主要成果:
- 由MSC衍生的miRNAs涉及治疗干眼,青光眼和视网膜退行性疾病.
- 来自MSC的细胞外囊泡有效地将miRNA传递到眼睛中的点细胞.
- 生物工程纳米微粒为基于miRNA的新型眼部药物治疗提供了一个平台.
结论:
- 从MSC衍生的miRNAs代表了各种眼部疾病的有前途的治疗策略.
- 细胞外囊泡和生物工程纳米囊泡是这些miRNA的关键传递系统.
- 对MSC-miRNA疗法的进一步研究可能会彻底改变眼科治疗.
相关概念视频
01:19Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
01:22iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K